Application of [68Ga]Ga-NI-FAPI-04 PET/CT Imaging in Fibroblast Activation Protein Related Diseases
Recruiting · NCT07464132 · Interventional (participants receive a specific treatment) · Lead sponsor: Peking Union Medical College Hospital
View the official record on ClinicalTrials.gov →Interventions studied
Injection of 68Ga-NI-FAPI
What this trial is about
The purpose of this study is to conduct clinical research on \[68Ga\] Ga-NI-FAPI-04 PET/CT imaging and further investigate its diagnostic value in fibroblast activation related diseases.
Who can take part
Age range
18 Years to 85 Years
Sex
All (male and female)
Healthy volunteers
Yes - healthy volunteers may be accepted
Phase
Phase 1, Phase 2
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- 1: 18-85 years old
- : Tumor patients can undergo surgery or biopsy to obtain pathological diagnosis
- : Ability to understand and sign informed consent forms
- : Expected survival period exceeding 6 months and able to receive follow-up
- : Healthy volunteers without chronic medical history of hypertension, diabetes, coronary heart disease, kidney disease, tumor, etc
Exclusion criteria
- 1: Pregnant or lactating women
- : Patients allergic to research drug ingredients
- : Patients with severe liver and kidney dysfunction (blood creatinine levels exceeding 159 μ mol/L)
- : Patients who participate in other clinical trials and interfere with the results of this study
- : Patients with severe illness who cannot cooperate with the examination
Where it is running
1 location listed.
- Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College - Beijing, Beijing Municipality, China